THC
19–30%
CBD
0.05%
SF-Z is a hybrid offered by Sherbinskis, showing an unusually wide lab-tested range of 19 to 30 percent THC potency.
No effect, terpene, flavor or medical-use data specific to SF-Z has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
30% THC
About SF-Z
Sherbinskis offers this hybrid under a name that reads like shorthand rather than a full strain title, and the lab data backs up the idea that this is a cultivar built for potency rather than subtlety. THC testing spans an unusually wide range, from 19 percent on the low end up to 30 percent at the top, which is one of the broader spreads recorded for any single cultivar in this collection. That kind of gap between minimum and maximum readings usually reflects real variation across harvests or phenotypes rather than lab error, so buyers picking up SF-Z should expect real differences in strength from one batch to the next. Sherbinskis has built a reputation around potent, resin-heavy genetics, and while the fact sheet doesn't confirm terpene content, flavor or effects for this particular listing, the THC ceiling alone puts it firmly in the upper tier of what's commercially available.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about SF-Z
Is SF-Z an Indica, Sativa, or Hybrid?
SF-Z is classified as a hybrid cannabis strain.
What cannabinoid content is reported for SF-Z?
SF-Z: 30% THC and 0.05% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.